HERG 스크리닝 시장 규모, 점유율, 성장 분석 : 유형별, 이온 채널별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global HERG Screening Market size was valued at USD 1.79 Billion in 2024 and is poised to grow from USD 2 Billion in 2025 to USD 4.88 Billion by 2033, growing at a CAGR of 11.8% during the forecast period (2026-2033).

The global hERG screening market is experiencing significant growth driven by heightened focus on drug safety and the demand for more efficient screening methods. The pharmaceutical and biotechnology sectors are key contributors to this trend, as they seek reliable technologies to mitigate the risk of drug-induced cardiac arrhythmias. Increased awareness of drug cardiotoxicity has underscored the importance of hERG screening in the drug development process. Advances in technologies, including automated patch clamp systems and high-throughput screening, are propelling market expansion. Additionally, stringent regulatory demands urge pharmaceutical companies to invest in hERG screening to ensure compliance. However, the high initial investment for sophisticated screening equipment poses a challenge for smaller companies and research institutions, while accurately predicting cardiac safety remains complex, necessitating ongoing research.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global HERG Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HERG Screening Market Segments Analysis

Global HERG Screening Market is segmented by Type, Ion Channel, Application and region. Based on Type, the market is segmented into Gene KCNH2 and Mutant KCNH2. Based on Ion Channel, the market is segmented into Voltage-Gated and Ligand-Gated. Based on Application, the market is segmented into Antiarrhythmic, Antiphyshotic, Antibiotics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HERG Screening Market

The growing focus on ensuring drug safety serves as a primary catalyst for the Global HERG Screening market, prompting companies to allocate resources toward innovative screening technologies. This investment is aimed at identifying potential compounds that may have adverse cardiac effects early in the drug discovery process. As regulatory pressures increase and the demand for safe pharmaceuticals rises, organizations recognize the importance of effective HERG screening in mitigating risks associated with drug development. Consequently, this emphasis on drug safety not only fosters advancements in screening methodologies but also enhances the overall efficacy and reliability of new therapeutic compounds entering the market.

Restraints in the Global HERG Screening Market

A significant challenge facing the Global HERG Screening market is the high cost associated with obtaining and maintaining advanced screening equipment, such as automated patch clamp systems. This substantial financial hurdle poses difficulties for smaller pharmaceutical companies and research institutions, limiting their access to cutting-edge hERG screening technologies. As a result, these organizations may struggle to keep pace with larger competitors that can more easily invest in necessary hardware and resources, ultimately impacting their capacity for innovation and research within the field of drug development. Such economic constraints can restrict overall market growth and the advancement of critical screening methodologies.

Market Trends of the Global HERG Screening Market

The Global HERG Screening market is experiencing a significant trend towards automation and high-throughput technologies, as companies increasingly seek efficient solutions for assessing drug safety profiles. The rising consumer awareness of clean label products has heightened the demand for rigorous screening processes to identify potential hERG liabilities in pharmaceutical compounds. Automated Patch Clamp Systems are gaining traction due to their capability for high throughput and precise measurements, streamlining the drug discovery workflow. This focus on High-Throughput Screening (HTS) technology enables researchers to evaluate numerous compounds simultaneously, ultimately accelerating the development of safer therapeutic options and enhancing regulatory compliance in the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global HERG Screening Market Size by Type & CAGR (2026-2033)

• Market Overview
• Gene KCNH2
• Mutant KCNH2

Global HERG Screening Market Size by Ion Channel & CAGR (2026-2033)

• Market Overview
• Voltage-Gated
• Ligand-Gated

Global HERG Screening Market Size by Application & CAGR (2026-2033)

• Market Overview
• Antiarrhythmic
• Antiphyshotic
• Antibiotics
• Others

Global HERG Screening Market Size & CAGR (2026-2033)

• North America (Type, Ion Channel, Application)
  • US
  • Canada
• Europe (Type, Ion Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Ion Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Ion Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Ion Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cytocentrics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanion Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB Drug Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B'SYS GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RedShift BioAnalytics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icagen, Inc. (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apredica (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotrem S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axxam S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ncardia AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations